<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154304">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091181</url>
  </required_header>
  <id_info>
    <org_study_id>2-valentin</org_study_id>
    <nct_id>NCT01091181</nct_id>
  </id_info>
  <brief_title>The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar</brief_title>
  <official_title>The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women who are to undergo their first Cesarean and have cervical dilatation 5 cm or more are
      randomized to having the hysterotomy 2 cm below or above the bladder insertion on the
      uterus. They are followed up with a transvaginal scan of the uterus 6 - 9 months after the
      Cesarean to assess the appearance of the Cesarean scar in the uterus.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Large defect in hysterotomy scar after caesarean</measure>
    <time_frame>6- 9 months after the Cesarean</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Uterine dehiscence or rupture in the subsequent pregnancy</measure>
    <time_frame>in the subsequent pregnancy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Scars</condition>
  <arm_group>
    <arm_group_label>2 cm above</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>At cesarean the hysterotomy is made 2 cm above the bladder insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 cm below</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>at cesarean hysterotomy is done 2 cm below the bladder insertion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysterotomy</intervention_name>
    <description>at cesarean hysterotomy is performed 2 cm above or below the bladder insertion</description>
    <arm_group_label>2 cm above</arm_group_label>
    <arm_group_label>2 cm below</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No previous caesarean

          -  5 cm cervical dilatation at least 18 years old
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Skåne University Hospital Malmö</name>
      <address>
        <city>Malmö</city>
        <zip>Se 20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lil Valentin, MD, PhD</last_name>
      <phone>+4640331000</phone>
      <phone_ext>2149</phone_ext>
      <email>lil.valentin@med.lu.se</email>
    </contact>
    <investigator>
      <last_name>Lil Valentin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 25, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Caesarean</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
